[EN] CONSTRAINED BENZHYDRYL SULFONAMIDES AS ANTICANCER AND NEUROPROTECTIVE AGENTS<br/>[FR] BENZHYDRYL SULFONAMIDES CONTRAINTS UTILISÉS EN TANT QU'AGENTS ANTICANCÉREUX ET NEUROPROTECTEURS
申请人:ICAHN SCHOOL MED MOUNT SINAI
公开号:WO2017044575A1
公开(公告)日:2017-03-16
A genus of arylsulfonamide derivatives of heterocyclic constrained tricyclic compounds is disclosed. The compounds are of the following genus: The compounds induce FOXO1 transcription factor translocation to the nucleus by modulating PP2A and, as a consequence, exhibit anti-proliferative effects. They are useful in the treatment of a variety of disorders, including as a therapy in cancer treatment, or used in combination with other drugs to restore sensitivity to chemotherapy where resistance has developed.
本文揭示了一种杂环限制三环化合物的芳基磺酰胺衍生物属。这些化合物属于以下属:这些化合物通过调节PP2A诱导FOXO1转录因子转位到细胞核,并因此表现出抗增殖效果。它们在治疗多种疾病中非常有用,包括癌症治疗中的治疗,或与其他药物结合使用以恢复对化疗的敏感性,其中产生了抗药性。